Key facts
- It has raised $1.8M; the latest was Seed Round ($750K) in May 2025.
- Notable investors include Startmate, LaunchVic, Archangel Ventures, M8 Ventures, Side Stage Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Elita
- ·The full record, as it builds
Funding rounds
No funding rounds for Elita are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Elita
Operator of a pet longevity platform intended to drive preventative care and earlier risk detection. The company offers integration of biological data, clinical histories, and owner observations, enabling pet owners and veterinarians to access personalised health guidance and improve long-term pet wellbeing.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Australia
- Founded
- 2023
- Employees
- 8
- Website
- elita.pet/
- Ownership
- Privately Held (backing)
Elita doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Elita shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Elita in its N-PORT filings yet. We sweep new filings monthly.